BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the medical technology company’s stock.

BIOLASE Price Performance

NASDAQ BIOL opened at $0.01 on Wednesday. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94. The company has a market capitalization of $325,718.25, a PE ratio of 0.00 and a beta of 0.67. The company has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.02.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.